New Chemo-Free combo aims to shrink lung tumors before surgery
NCT ID NCT07231575
First seen Nov 17, 2025 · Last updated May 09, 2026 · Updated 19 times
Summary
This study tests a new drug combination given before surgery for people with early-stage non-small cell lung cancer that does not have certain gene changes. The treatment uses focused radiation, an immunotherapy drug, and a targeted therapy to shrink tumors without standard chemotherapy. The goal is to see if this approach can eliminate all cancer cells in the removed tissue and reduce the chance of the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.